In the public perception, immunosuppressants appear to be “patents” for organ transplant patients and have nothing to do with the lives of ordinary people. However, this is an area of error that needs to be corrected.
Immunosuppressants are, by name, a class of drugs that can inhibit the functioning of the human immune system. Its main role is to reduce attacks by the immune system on its own tissue or on transplanted organs by intervening in the human immune response. It does play an indispensable role in the field of organ transplantation. When patients undergo transplantation of vital organs, such as the heart, liver and kidney, their own immune system will instinctively recognize the transplanted organ as a “other” and launch an attack in an attempt to remove it. Immunosuppressants, like peacekeeping forces, reduce immune attacks by inhibiting the activity of immunosuppressors, thereby increasing the survival of transplanted organs and helping patients through critical post-operative periods. Ethylene, for example, is a classic immunosuppressant that precisely inhibits the activation of T lymphocytes, significantly reduces the incidence of exclusionary responses to transplants, and brings back to life many organ transplant patients.
But the application of immunosuppressants is by no means limited. Such drugs are also widely used in the treatment of autoimmune diseases. Like rheumatism, which is a common self-immunological disease, patients ‘ immune systems wrongly attack their own joints, causing joint pain, swelling and deformity. Immunosuppressants, such as aminos, can effectively regulate the immune system, reduce the response to immunitis, mitigate the symptoms of joints, slow the progress of the disease and improve the quality of life of patients. The same is true for the systematic erythalamus, where the immune system of the patient is disturbed and its own antibody is produced in large numbers, attacking multiple organs and systems throughout the body. Immunosuppressants can inhibit excessively active immune systems and reduce damage to kidneys, skin, heart, etc.
Immunosuppressants are also useful in some cases of severe skin disease treatment. For example, in the case of silver crumbs, the skin of a patient is sorely red and scavenging. Immunosuppressants can control skin inflammation and improve skin symptoms from the point of view of regulating immunisation for patients with more serious conditions and poor routine treatment. There are also eye immunological diseases, such as grapes, and immunosuppressants can reduce the immune response to eye diseases and prevent visual impairment.
However, immunosuppressants are not without risk. By inhibiting the immune system, patients are more vulnerable to various pathogens during their use. Just as a city ‘ s defence system is weakened, the risk of external invasion increases. Pathogens such as bacteria, viruses and fungi may take advantage of their infestation, causing infectious diseases such as pneumonia, urinary tract infections and herpes. Furthermore, the long-term use of immunosuppressants may increase the risk of tumours. Because of the ability of the immune system to monitor and remove tumour cells, opportunities for tumour cells to occur and develop may increase when this function is suppressed.
For the general population, although not as long-term dependence on immunosuppressants as for organ transplant patients, exposure may occur in certain specific situations. For example, some relatives suffering from their own immuno-immunological diseases may be using immunosuppressants in their family life and learning about them will help to better care for the patient and provide protection. Or, in some areas of medical beauty, some irregular beauty-dressing institutions may have violated the use of immunosuppressants to treat skin problems, which undoubtedly poses enormous health risks to users.
The application of immunosuppressants is far beyond public awareness and has an important place in the treatment of a wide range of diseases. We need to be aware of its important value in the field of health, as well as of the risks associated with its use. Immunosuppressants should be viewed in the right way, both by medical professionals and the general public, so as to break the false cognitive limitations of “only for organ transplant patients” and to make them better served in the health and treatment of patients under reasonable medical supervision and application.
